SCT
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SCT in Ph Positive Acute Lymphoblastic Leukemia (NCT03821727) | CANDONI ANNA | 2016-10-26 |
| Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT (NCT02872662) | Nordic MDS Group | 2016-08-01 |
Track SCT automatically
Every clearance here is in the API, with alerts when new ones post.